Methotrexate encephalopathy: Two cases in adult cancer patients, who recovered with pathophysiologically based therapy

by Shodeinde A Coker, David A Pastel, Melissa C Davis, Elizabeth M Bengtson, Camilo E Fadul, Lionel D Lewis
Published 2017-05-01

A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia

by Darcy B. Pooler, Dylan B. Ness, Alexey V. Danilov, Bridget M. Labrie, Tor D. Tosteson, Alan Eastman, Lionel D. Lewis, Frederick Lansigan
Published 2022-11-01

A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma

by Dylan B. Ness, Darcy B. Pooler, Steven Ades, Brian J. Highhouse, Bridget M. Labrie, Jie Zhou, Jiang Gui, Lionel D. Lewis, Marc S. Ernstoff
Published 2023-06-01

Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo.

by Christian NDong, Jennifer A Tate, Warren C Kett, Jaya Batra, Eugene Demidenko, Lionel D Lewis, P Jack Hoopes, Tillman U Gerngross, Karl E Griswold
Published 2015-01-01

VISTA expression and patient selection for immune-based anticancer therapy

by Alexander S. Martin, Michael Molloy, Andrey Ugolkov, Reinhard W. von Roemeling, Randolph J. Noelle, Randolph J. Noelle, Lionel D. Lewis, Melissa Johnson, Laszlo Radvanyi, Robert E. Martell, Robert E. Martell
Published 2023-02-01

Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Trans...

by Adrianna L. De La Torre, Thao N. Huynh, Catherine C. Y. Chang, Darcy B. Pooler, Dylan B. Ness, Lionel D. Lewis, Sanjana Pannem, Yichen Feng, Kimberley S. Samkoe, William F. Hickey, Ta Yuan Chang
Published 2023-07-01

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

by Pallawi Torka, Swetha Kambhampati, Lu Chen, Xiaoguang Wang, Canping Chen, Dan Vuong, Hanjun Qin, Alexandra Muir, Kirsten Orand, Ivana Borja, D. Lynne Smith, Alex F. Herrera, Stephen E. F. Spurgeon, Byung Park, Lionel D. Lewis, Francisco Hernandez-Ilizaliturri, Zheng Xia, Alexey V. Danilov
Published 2023-01-01

Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

by Asim Amin, Elizabeth R Plimack, Marc S Ernstoff, Lionel D Lewis, Todd M Bauer, David F McDermott, Michael Carducci, Christian Kollmannsberger, Brian I Rini, Daniel Y C Heng, Jennifer Knox, Martin H Voss, Jennifer Spratlin, Elmer Berghorn, Lingfeng Yang, Hans J Hammers
Published 2018-10-01

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

by Asim Amin, Elizabeth R. Plimack, Marc S. Ernstoff, Lionel D. Lewis, Todd M. Bauer, David F. McDermott, Michael Carducci, Christian Kollmannsberger, Brian I. Rini, Daniel Y. C. Heng, Jennifer Knox, Martin H. Voss, Jennifer Spratlin, Elmer Berghorn, Lingfeng Yang, Hans J. Hammers
Published 2019-03-01

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights

by Randolph J. Noelle, Randolph J. Noelle, J. Louise Lines, Lionel D. Lewis, Robert E. Martell, Robert E. Martell, Thierry Guillaudeux, Sam W. Lee, Kathleen M. Mahoney, Kathleen M. Mahoney, Matthew D. Vesely, Jerome Boyd-Kirkup, Dhanya K. Nambiar, Andrew M. Scott, Andrew M. Scott
Published 2023-09-01